Additionally, APOE4, which confers increased susceptibility in developing AD, has been considered as a marker that increases the severity of COVID-19 (26) therefore, AD patients who carry the APOE4 allele have a higher risk of developing COVID-19. This evidence concerns the gene APOE and COVID-19.